E

Genix Pharmaceuticals Corporation GENX.V

TSX
Recommendation
Dividend Power Score
Day's Range
$0.02$0.02
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

GENX.V Rating

Reward
Risk

GENX.V Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

GENX.V Company Overview

Genix Pharmaceuticals Corporation (ticker: GENPF) is a development-stage pharmaceutical company whose publicly disclosed activities indicate a focus on the pharmaceutical and life sciences sector, primarily involving the development, licensing, or commercialization of therapeutic products. Based on available public disclosures, the company does not report material commercial revenues and appears to operate with a limited operational footprint typical of early-stage or dormant pharmaceutical entities. Its shares trade on the OTC Markets, and the company has historically been characterized by minimal public reporting compared with fully reporting SEC registrants.

Public records indicate that Genix Pharmaceuticals Corporation has undergone corporate transitions and periods of limited activity, with no consistently documented portfolio of marketed products. As a result, its strategic positioning is not clearly differentiated relative to peers, and no defensible competitive advantages have been conclusively documented in recent filings. Data inconclusive based on available public sources regarding active proprietary drug platforms or sustained commercial operations.

Data compiled by narrative technology. May contain errors.

GENX.V Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

GENX.V Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

GENX.V Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

GENX.V Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

GENX.V Valuation

Market Cap
Market Cap Rank
#18,156
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

GENX.V Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

GENX.V Corporate Info

Phone Number
604-609-6198
Address
1055 West Hastings Street
Suite 300
Vancouver, BC V6E 2E9
Country
Year Founded

GENX.V Filings

Filing Date
Saturday, June 27, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
(est)

GENX.V Headlines

There are no news to display.